CAPTRUST Financial Advisors
IBIO icon

CAPTRUST Financial Advisors’s iBio IBIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed – – 2980
2022
Q2 		$0 Hold
3
– – ﹤0.01% 5023
2022
Q1 		$1K Hold
3
– – ﹤0.01% 4701
2021
Q4 		$1K Hold
3
– – ﹤0.01% 4577
2021
Q3 		$2K Hold
3
– – ﹤0.01% 4263
2021
Q2 		$2K Hold
3
– – ﹤0.01% 4174
2021
Q1 		$2K Buy
+3
New +$2.61K ﹤0.01% 4045

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CAPTRUST Financial Advisors's IBIO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of iBio (IBIO) in Q3 2022, closing a stake of 3 shares.

CAPTRUST Financial Advisors first reported a position in IBIO in Q1 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 43 funds tracked by Wall St. Rank hold IBIO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining iBio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3 iBio shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in iBio in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's iBio position peaked at $2K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held iBio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.